Head-to-head
Found vs NovoCare Pharmacy (Wegovy)
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. Found is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Found is $289 a month all-in for semaglutide; NovoCare Pharmacy (Wegovy) is $349. Over twelve months that is $3,468 against $4,188. Value Scores are 48.8 and 37.4 out of 100.
Semaglutide
Plan pages: Found plans · NovoCare Pharmacy (Wegovy) plans
At 2.4 mg/week, Found is $289 a month all-in and NovoCare Pharmacy (Wegovy) is $349 — $60 apart, or $720 across a year. Over twelve months the totals are $3,468 (billed monthly) and $4,188 (billed monthly).
Found charges a flat $289 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Found | NovoCare Pharmacy (Wegovy) | Cheaper |
|---|---|---|---|
| 0.25 mg | $289 | $349 | Found by $60 |
| 0.5 mg | $289 | $349 | Found by $60 |
| 1 mg | $289 | $349 | Found by $60 |
| 1.7 mg | $289 | $349 | Found by $60 |
| 2.4 mg | $289 | $349 | Found by $60 |
Found is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, the field median is $199 a month all-in. Found, at $289, is $90 above it; NovoCare Pharmacy (Wegovy), at $349, is $150 above it.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide price in this database, is $349 a month at 2.4 mg/week — Found is $60 below it. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Found | NovoCare Pharmacy (Wegovy) | Cheaper |
|---|---|---|---|
| Month to month | $289 | $349 | Found by $60 |
| Settled dose | Found | NovoCare Pharmacy (Wegovy) | Difference |
|---|---|---|---|
| 0.25 mg | $3,468 | $4,188 | $720 apart |
| 0.5 mg | $3,468 | $4,188 | $720 apart |
| 1 mg | $3,468 | $4,188 | $720 apart |
| 1.7 mg | $3,468 | $4,188 | $720 apart |
| 2.4 mg | $3,468 | $4,188 | $720 apart |
Found publishes no rate for 3-month term, 6-month term, 12-month term; NovoCare Pharmacy (Wegovy) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $3,468 on Found and $4,188 on NovoCare Pharmacy (Wegovy). The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 48.8 for Found and 37.4 for NovoCare Pharmacy (Wegovy), against a semaglutide category floor of $87. Found leads by 11.4 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Found | 21.1 | 12.8 | 10 | 5 | 48.8 |
| NovoCare Pharmacy (Wegovy) | 17.4 | 15.0 | 0 | 5 | 37.4 |
Where the two programs differ
All-in monthly
Found is cheaper month to month — $289 against $349, a gap of $60 every month, or $720 across a year if both rates hold.
Cancellation terms
Cancellation differs: Found states Per plan terms, while NovoCare Pharmacy (Wegovy) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Found asks for Program-based; NovoCare Pharmacy (Wegovy) asks for None. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Found charges one price at every dose; NovoCare Pharmacy (Wegovy) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Found's figure is provider-stated and NovoCare Pharmacy (Wegovy)'s is verified. NovoCare Pharmacy (Wegovy) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $3,468 for Found and $4,188 for NovoCare Pharmacy (Wegovy). Found is lower by $720 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Found Official site
Found layers behavior-change coaching over medication access; compounded pricing lands at $289/month for tirzepatide and $289 at semaglutide maintenance (from a $169 start).
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinfound.com pricing capture 2026-08-05
Watch: Program bundles differ; confirm which plan a quoted price belongs to before comparing.
NovoCare Pharmacy (Wegovy) Official site
Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses (0.25 to 2.4 mg) and $399 for the 7.2 mg Wegovy HD pen, with $199 for each of a new patient's first two 0.25 mg or 0.5 mg fills through December 31, 2026, and the Wegovy pill at $149 (1.5 mg), $199 (4 mg) and $299 (9 and 25 mg) a month. It is the lowest FDA-approved semaglutide pen price in this database and the benchmark for every compounded semaglutide quote.
It names its compounding pharmacy — CoAssist Pharmacy d/b/a NovoCare Pharmacy, recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — novocare.com price guide and savings-offer pages, retrieved 2026-08-11
Watch: The $199 new-patient offer ends December 31, 2026; the standing numbers are $349 for the pen and $399 for Wegovy HD.
Which molecules each one carries
Found carries tirzepatide at $289 a month and semaglutide at $289 a month.
NovoCare Pharmacy (Wegovy) carries semaglutide at $349 a month; does not offer tirzepatide.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Found does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
NovoCare Pharmacy (Wegovy) does not publish
- no published twelve-month semaglutide rate
Ask Found and NovoCare Pharmacy (Wegovy) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lower standing monthly rate for semaglutide, Found Official site wins this matchup. If you expect to titrate to the top of the ladder, found's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, novocare pharmacy (wegovy)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Found's semaglutide price is provider-stated as of 2026-08-05; NovoCare Pharmacy (Wegovy)'s is verified as of 2026-08-11.
Questions
Is Found or NovoCare Pharmacy (Wegovy) cheaper for semaglutide?
Found is cheaper on all-in monthly cost at 2.4 mg/week: $289 against $349, a difference of $60 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Found versus NovoCare Pharmacy (Wegovy)?
Found works out to $3,468 across twelve months and NovoCare Pharmacy (Wegovy) to $4,188, on the plan terms each publishes.
Does Found or NovoCare Pharmacy (Wegovy) raise the price as the dose goes up?
Found: no, it charges one flat rate at every dose. NovoCare Pharmacy (Wegovy): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Found and NovoCare Pharmacy (Wegovy) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Found and NovoCare Pharmacy (Wegovy) names its pharmacy?
NovoCare Pharmacy (Wegovy) does — CoAssist Pharmacy d/b/a NovoCare Pharmacy. Found does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Found and NovoCare Pharmacy (Wegovy) prices?
Found's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. NovoCare Pharmacy (Wegovy)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Found official site · NovoCare Pharmacy (Wegovy) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.